The old playbook is officially dead. This is no longer a market where everything pumps together. Liquidity is being pulled selectively, and the next phase belongs only to projects that can generate real demand when easy money dries up. We are in a regime shift, and narrative-heavy stories without substance are becoming casualties. $TRX is currently testing a critical recovery zone between $0.3490 and $0.3515. As long as this area holds, the path is clear: TP1 at $0.3545, TP2 at $0.3585, and TP3 at $0.3645. Invalidation comes on a firm break below $0.3425. The key question isn't whether TRX can bounce, but whether buyers can reclaim the recent range high and push for continuation. Meanwhile, the broader market is sending cold signals. BTC, ETH, and SOL haven't signaled full risk-off mode yet, but assets like XRP, BNB, TRX, and DOGE are already trading defensively. Capital preservation is quietly replacing speculation. Danger zones remain concentrated in high-beta narratives. SUI, TON, CORE, AI, GRASS, TRUTH, BSB, LAYER, MERL, and ENSO continue to offer explosive volatility, but volatility is not strength. Fast candles can easily mask weak liquidity and fragile market structure. On the flip side, names like LIT, PROVE, BASED, EDGE, SPACE, TRIA, BLUR, PENGU, HUMA, NOT, BIO, AR, and FIL are still struggling to produce convincing recoveries. And crowded trades including HYPE, ZEC, ONDO, ORDI, PI, AEVO, JUP, PYTH, TIA, SEI, and INJ could face massive pressure if conditions worsen. The real leaders are often the ones no one talks about. Watch closely: NEAR, WLD, LAB, BILL, ICP, PROS, and ENA continue to show relative strength while the rest of the market stays under pressure. This is not a headline-chasing market.